FLT3 Inhibitors as Maintenance Therapy Post Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia Patients with FLT3 Mutations: A Meta-Analysis

The authors compared overall survival, relapse-free survival, cumulative incidence of relapse, non-relapse mortality, graft-versus-host disease, and adverse events between FLT3 inhibitors and control groups.